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http://dx.doi.org/10.1016/j.ccr.2014.03.010SUMMARYThe role of TGF-b-induced epithelial-mesenchymal transition (EMT) in cancer cell dissemination is well
established, but the involvement of lncRNAs in TGF-b signaling is still unknown. In this study, we observed
that the lncRNA-activated by TGF-b (lncRNA-ATB) was upregulated in hepatocellular carcinoma (HCC)
metastases and associated with poor prognosis. lncRNA-ATB upregulated ZEB1 and ZEB2 by competitively
binding the miR-200 family and then induced EMT and invasion. In addition, lncRNA-ATB promoted organ
colonization of disseminated tumor cells by binding IL-11 mRNA, autocrine induction of IL-11, and triggering
STAT3 signaling. Globally, lncRNA-ATB promotes the invasion-metastasis cascade. Thus, these findings
suggest that lncRNA-ATB, a mediator of TGF-b signaling, could predispose HCC patients to metastases
and may serve as a potential target for antimetastatic therapies.INTRODUCTION
Hepatocellular carcinoma (HCC) is one of the most common
and aggressive human malignancies in the world (Jemal et al.,
2011). The poor prognosis and high recurrence rate of HCC is
largely due to the high rate of intrahepatic and extrahepatic
metastases (Budhu et al., 2006). This emphasizes the urgency
of identifying these patients in advance and establishing new
therapeutic targets for successful intervention. Metastasis is a
complex process, and many cell-intrinsic identities and extrinsic
microenvironment factors influence the metastatic potential
of HCC cells (Fidler, 2003). However, the underlying molecular
mechanisms that mediate the metastatic cascade remain
largely unclear. Enhancing our understanding of the molecular
mechanisms may promote the development of effective metas-
tasis-targeted therapy and improve the overall prognosis of
patients with HCC.Significance
Metastases account for the vast majority of cancer-associated
tumor invasion. However, the tumor-suppressive role of TGF-b
involvement of EMT inmetastatic colonization is still hotly deba
can mimic the prometastatic role of TGF-b. lncRNA-ATB induc
tion of disseminated tumor cells. High expression of lncRNA-A
ATBmay serve as a target for therapeutic intervention against
patients present with circulating tumor cells.
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(TGF-b) orchestrates an intricate signaling network to modulate
tumorigenesis and progression (Majumdar et al., 2012; Mas-
sague´, 2008). TGF-b exerts its tumor-suppressive role by
inducing cell-cycle arrest and apoptosis (Pardali andMoustakas,
2007). Nevertheless, TGF-b also promotes tumor progression
through enhancing proliferation, migration, and invasion, in part
by its ability to induce epithelial-mesenchymal transition (EMT)
(Akhurst and Hata, 2012). EMT has been shown to be of critical
importance in the early events of tumor cell metastatic dissemi-
nation by endowing cells with a more motile, invasive potential
(Thiery et al., 2009). However, the involvement of EMT and its
reverse process, mesenchymal-epithelial transition (MET) in the
late events of tumor cell metastasis, such as distant colonization,
are still hotly debated (Ocan˜a et al., 2012; Tsai et al., 2012). The
multiple and often contradictory functions of TGF-b necessitate
both a better understanding of the special downstream effectorsdeaths and TGF-b-induced EMT has been associated with
hinders the application of anti-TGF-b cancer treatments. The
ted.We found that lncRNA activated by TGF-b (lncRNA-ATB)
ed EMT and tumor cell invasion and promoted the coloniza-
TB is a robust predictor of poor survival. Therefore, lncRNA-
cancer metastases early in the metastatic process and when
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b-dependent pathways for HCC treatment.
Long noncoding RNAs (lncRNAs) are a class of transcripts
longer than 200 nucleotides with limited protein coding potential.
Recently, many studies have shown that lncRNAs are frequently
deregulated in various diseases and have multiple functions in
a wide range of biological processes, such as proliferation,
apoptosis, or cell migration (Mercer et al., 2009; Ponting et al.,
2009). Although several lncRNAs have been reported to modu-
late tumor metastases (Gupta et al., 2010; Prensner et al.,
2013), the specific roles of lncRNAs in mediating the prometa-
static role of TGF-b and regulating EMT are not well studied. In
this study, we report the identification of lncRNA-AL589182.3
(ENST00000493038), which we have named lncRNA-activated
by TGF-b (lncRNA-ATB), and focus on the role of lncRNA-
ATB in TGF-b signaling and in the invasion-metastasis cascade
of HCC.
RESULTS
lncRNA-ATB Is Upregulated by TGF-b and Is Physically
Associated with the miR-200 Family
To identify lncRNAs that are regulated by TGF-b and mediated
the role of TGF-b in inducing EMT, we treated SMMC-7721 hep-
atoma cells continuously with TGF-b for 21 days, which caused
SMMC-7721 cells to undergo EMT, as indicated by a spindle-
shaped appearance (Figure S1A available online), decreased
expression of the epithelial marker CDH1, and increased expres-
sion of the mesenchymal markers and transcription factors
CDH2, VIM, ZEB1, SNAI1, and TWIST1 (Figure S1B). We then
used microarray analysis to compare lncRNA expression levels
between TGF-b treated and untreated cells, and found 676
upregulated and 297 downregulated lncRNAs in the treated cells
(Table S1). Microarray results also indicated that TGF-b treat-
ment led to EMT gene expression signature (Figure S1C; Huang
et al., 2012) and gene set enrichment analysis (GSEA; Subrama-
nian et al., 2005) indicated that four published TGF-b response
signatures (Calon et al., 2012; Kang et al., 2003; Padua et al.,
2008) were significantly enriched in the treated cells (Figure S1D),
which further confirmed that the microarray results were trust-
able and TGF-b treatment for 21 days indeed induced EMT.
Recently, many RNA transcripts have been reported to func-
tion as competing endogenous RNAs (ceRNA) by competitively
binding common microRNAs (Cesana et al., 2011; Salmena
et al., 2011; Tay et al., 2011). The miR-200 family, including
miR-200a, miR-200b, miR-200c, miR-141, and miR-429, has
been reported to repress EMT and tumor invasion by targeting
the 30UTRs of ZEB1 and ZEB2 (Burk et al., 2008; Gregory
et al., 2008). Among the deregulated lncRNAs, we predicted 76
miR-200s targeting sites on 46 lncRNAs (Table S2) using the Tar-
getScan prediction algorithm (Lewis et al., 2005; http://www.
targetscan.org/). Interestingly, one of the upregulated lncRNAs,
lncRNA-ATB, which has a relatively large fold change, has three
predicted miR-200s targeting sites in a relatively short span (Fig-
ures 1A and 1B), indicating a strong possibility as a ceRNA (Tay
et al., 2011).
To confirm the microarray result, we treated SMMC-7721 and
the normal liver cell line QSG-7701 with TGF-b and measured
the expression of lncRNA-ATB at various time points. TGF-binduced a robust increase of lncRNA-ATB in both cells, not
only in the long-term treatment, but also in short-term treatment
(Figures 1C–1F). In breast cancer cell line MCF7 and colorectal
cancer cell line SW480, TGF-b also upregulated lncRNA-ATB
(Figures S1E and S1F).
Thesequenceof full-length lncRNA-ATB ispresented inFigures
S1G and S1H. Northern blot analysis of lncRNA-ATB confirmed
the expected size (Figure 1G). Using a BLAST search of the
sequence of lncRNA-ATB against the human genome, we found
another three highly homologous lncRNA-ATB loci on chromo-
somes 13, 14, and 22, suggesting theremay be an lncRNA family,
which includes lncRNA-ATB. lncRNA-ATB was poly (A)-negative
and mainly located in the cytoplasm (Figures S1I and S1J).
Analysis of thesequencesbyORFFinder from theNationalCenter
for Biotechnology Information failed to predict a protein of
more than 55 amino acids (Figure S1K). Moreover, lncRNA-ATB
does not contain a valid Kozak sequence. In addition, we used
txCdsPredict fromUCSCandPhyloCSF (Lin et al., 2011) to calcu-
late its coding potential. The txCdsPredict score of lncRNA-ATB
is 309.5 and the codon substitution frequency score is lower
than 500 (Figure S1L), which further supports that lncRNA-
ATBhasnoprotein-codingpotential. Ananalysiswithquantitative
(q)RT-PCR revealed a significantly higher expression of lncRNA-
ATB in HCC cells than in normal liver cells, especially in highly
metastatic cells (Figures S1M and S1N).
To validate the direct binding between miR-200s and lncRNA-
ATBat endogenous levels,weperformedanRNA immunoprecip-
itation (RIP) to pull down endogenous microRNAs associated
with lncRNA-ATB and demonstrated via qPCR analysis that the
lncRNA-ATB RIP in SMMC-7721 cells was significantly enriched
for miR-200s compared to the empty vector (MS2), IgG, non-
targeting microRNA (miR-122), lncRNA-ATB with mutations
in miR-200s targeting sites (henceforth named ATB-mut(miR-
200)), and another lncRNA-ENST00000508851 (RP11-893F2.9;
henceforth named lncRNA-508851), which is also induced by
TGF-b, but does not have a predicated miR-200s targeting
site (Figure 1H; Figure S1O). The specific association between
miR-200s and lncRNA-ATB was further validated by affinity
pull-down of endogenous miR-200s using in vitro transcribed
biotin-labeled lncRNA-ATB (Figure 1I). For further confirmation,
we constructed luciferase reporters containing the 30 500nt of
lncRNA-ATB, which contains wild-type (WT) or mutated miR-
200s binding sites. We found that overexpression of miR-200s
reduced the luciferase activities of the WT reporter vector but
not empty vector or mutant reporter vector (Figure 1J). However,
we found no significant difference in lncRNA-ATB levels after
overexpression of miR-200s (Figure S1P). The microRNAs are
known to bind their targets and cause translational repression
and/or RNA degradation in an AGO2-dependent manner. To
determine whether lncRNA-ATB was regulated by miR-200s
in such a manner, we conducted anti-AGO2 RIP in SMMC-
7721 cells transiently overexpressing miR-200s. Endogenous
lncRNA-ATB pull-down by AGO2 was specifically enriched in
miR-200s-transfected cells (Figure 1K), supporting that miR-
200s are bona fide lncRNA-ATB-targeting microRNAs. These
data demonstrated that miR-200s bound to lncRNA-ATB but
did not induce the degradation of lncRNA-ATB. Ectopically
expressed lncRNA-ATB WT, but not the mutant or lncRNA-
508851, reduced the levels of miR-200s (Figure S1Q). To functionCancer Cell 25, 666–681, May 12, 2014 ª2014 Elsevier Inc. 667
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be comparable. We therefore used quantitative real-time PCR to
quantify the exact copy numbers of lncRNA-ATB and miR-200s
per cell in TGF-b treated and untreated SMMC-7721 cells. We
formulated standard curves with limit dilution approaches using
lncRNA-ATB expressing vector pcDNA3.1-ATB and reverse-
transcribed miR-200s cDNA as standard templates, and then
the exact copy numbers of lncRNA-ATB and miR-200s per cell
were calculated according to cell counts and molecular weights.
As a result, we found that in the untreated cells, the expression
level of lncRNA-ATB was approximately 100 copies per cell,
and mature miR-200s levels were approximately 200 copies per
cell. TGF-b treatment induced upregulation of lncRNA-ATB and
downregulation of miR-200s (Figure S1R). This result implied
that lncRNA-ATB may be able to function as a ceRNA for miR-
200s. All these data demonstrated that lncRNA-ATB physically
associatedwith themiR-200 family andmay function as a ceRNA.
lncRNA-ATB Upregulates ZEB1 and ZEB2 Levels
Because lncRNA-ATB shares regulatory miR-200s with ZEB1
and ZEB2, we wondered whether lncRNA-ATB could modulate
ZEB1 and ZEB2 and then EMT and invasion of HCC cells. We
stably overexpressed lncRNA-ATB WT, lncRNA-ATB-mut(miR-
200), and lncRNA-508851 in SMMC-7721 cells (Figure 2A; Fig-
ure S2A). The overexpression level of mutant clone is similar to
that of WT overexpression clone 1, which is also comparable
to that in highly metastatic HCCLM6 cells. For the rescue exper-
iment, we stably overexpressed miR-200a in lncRNA-ATB
overexpression clone 1 (Figure S2B). Overexpression of
lncRNA-ATB WT, but not the mutant or lncRNA-508851,
increased ZEB1 and ZEB2 transcript and protein levels in a
dose-dependent manner. Ectopic expression of miR-200a abro-
gated this increase (Figures 2B and 2C). In QSG-7701 cells, sta-
ble overexpression of lncRNA-ATB also upregulated ZEB1 and
ZEB2 (Figures 2D–2F). Additionally, HCCLM6 cells with stably
downregulated lncRNA-ATB or lncRNA-508851 were also con-
structed, which do not have any effect on other family members
of lncRNA-ATB (Figure 2G; Figures S2C andS2D). For the rescue
experiment, we inhibited miR-200a in lncRNA-ATB downregu-
lated HCCLM6 clone 1 (Figure S2E). The depletion of lncRNA-
ATB, but not lncRNA-508851, decreased ZEB1 and ZEB2 in a
dose-dependent manner. Inhibition of miR-200a overcame the
decrease of ZEB1 and ZEB2 (Figures 2H and 2I).
To ascertain whether this observed effect depends on regula-
tion of the ZEB1 and ZEB2 30UTR, we constructed luciferase
reporters containing either the ZEB1 or ZEB2 30UTR (pmirGLO-
ZEB1 or pmirGLO-ZEB2). Luciferase plasmid (pmirGLO-ZEB1,Figure 1. lncRNA-ATB Is Upregulated by TGF-b and Interacts with miR
(A) Schematic outlining the predicted binding sites of miR-200s on lncRNA-ATB.
(B) The prediction for miR-200s binding sites on lncRNA-ATB transcript. The red
(C–F) Relative expression of lncRNA-ATB in SMMC-7721 cells or QSG-7701 cel
(G) Northern blot analysis of lncRNA-ATB in HCC cells.
(H) MS2-RIP followed by microRNA qRT-PCR to detect microRNAs endogenous
(I) SMMC-7721 cell lysates were incubated with biotin-labeled lncRNA-ATB; afte
(J) Luciferase activity in SMMC-7721 cells cotransfected with miR-200s and lucif
presented as the relative ratio of firefly luciferase activity to renilla luciferase acti
(K) Anti-AGO2 RIP was performed in SMMC-7721 cells transiently overexpressin
associated with AGO2.
Data are shown as mean ± SD; n = 3. *p < 0.05, **p < 0.01, ***p < 0.001 (StudenpmirGLO-ZEB2, or the control reporter [pmirGLO]) was trans-
fected into the different SMMC-7721 and HCCLM6 cell clones.
Overexpression of lncRNA-ATB, but not the mutant or lncRNA-
508851, increased the luciferase activity of pmirGLO-ZEB1 and
pmirGLO-ZEB2 inadose-dependentmanner.Ectopic expression
of miR-200a abolished this upregulation (Figure 2J). Reciprocally,
the depletion of lncRNA-ATB, but not lncRNA-508851, decreased
the luciferase activity of pmirGLO-ZEB1 and pmirGLO-ZEB2,
which were rescued by inhibition of miR-200a (Figure 2K).
Because lncRNA-ATB could upregulate ZEB1 and ZEB2,
we next examined whether lncRNA-ATB is coexpressed with
ZEB1 and ZEB2 in human HCC samples. We measured the
expression levels of lncRNA-ATB, ZEB1, and ZEB2 in 86 human
HCC tissues. As shown in Figures 2L and 2M, lncRNA-ATB
transcript level was significantly correlated with ZEB1 or ZEB2
mRNA level. All these results suggest an important role of
lncRNA-ATB in modulating ZEB1 and ZEB2 by competitively
binding miR-200s.
lncRNA-ATB Induces EMT and Cell Invasion In Vitro
To investigate whether lncRNA-ATB regulates EMT through
modulating ZEB1 and ZEB2, we first examined the effect of
lncRNA-ATB on cell phenotypes. Overexpression of lncRNA-
ATBWT, but not the mutant or lncRNA-508851, induced mesen-
chymal-like morphological feature in SMMC-7721 cells. Ectopic
expression of miR-200a caused lncRNA-ATB overexpressed
cells to revert to an epithelial phenotype (Figure 3A). Analysis of
theepithelialmarkers E-cadherin andZO-1and themesenchymal
markers N-cadherin and vimentin revealed that overexpression
of lncRNA-ATB, but not the mutant or lncRNA-508851, reduced
E-cadherin and ZO-1 and increased N-cadherin and vimentin.
Consistently, ectopic expression of miR-200a abolished the
effects (Figures3Band3C). Immunofluorescencestainingalso re-
vealed that overexpression of lncRNA-ATB, but not themutant or
lncRNA-508851, induced lossof E-cadherin andZO-1expression
from the cell membrane, and increased N-cadherin and vimentin,
which was also abolished by overexpression of miR-200a (Fig-
ure 3D). Conversely, the depletion of lncRNA-ATB, but not
lncRNA-508851, induced an epithelial phenotype, upregulated
E-cadherin and ZO-1, as well as downregulated N-cadherin and
vimentin in HCCLM6 cells, which were also abrogated by
inhibition of miR-200a (Figures 3E–3G). Moreover, depletion of
lncRNA-ATB attenuated TGF-b-induced EMT in SMMC-7721
cells (Figure S3A; Figures 3H and 3I). Overexpression of
lncRNA-ATB also induced EMT in QSG-7701 cells and MCF7
cells (Figures S3B–S3H). To further support this conclusion, we
construct stable SMMC-7721 cell clone that overexpressed-200s
nucleotides are the seed sequences of microRNAs.
ls treated with TGF-b1 for the indicated time was measured by qRT-PCR.
ly associated with lncRNA-ATB.
r pull-down, microRNAs was extracted and assessed by qRT-PCR.
erase reporters containing nothing, lncRNA-ATB or mutant transcript. Data are
vity.
g miR-200s, followed by qRT-PCR to detect lncRNA-ATB or lncRNA-508851
t’s t test). See also Figure S1 and Tables S1 and S2.
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Figure 2. Regulation of ZEB1 and ZEB2 by lncRNA-ATB
(A) The expression of lncRNA-ATB in stable SMMC-7721 cell clones.
(B and C) The mRNA (B) or protein (C) levels of ZEB1 and ZEB2 in stable SMMC-7721 cell clones.
(D) The expression of lncRNA-ATB in stable QSG-7701 cell clones.
(E and F) The mRNA (E) or protein (F) levels of ZEB1 and ZEB2 in stable QSG-7701 cell clones.
(G) The expression of lncRNA-ATB in stable HCCLM6 cell clones.
(H and I) The mRNA (H) or protein (I) levels of ZEB1 and ZEB2 in stable HCCLM6 cell clones.
(legend continued on next page)
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andmiR-200a simultaneously overexpressedclone1 (FigureS3I).
Our results indicate that overexpression of lncRNA-ATB rescued
the downregulation of ZEB1 and ZEB2 and the inhibition of EMT
caused by ectopic expression of miR-200a (Figures S3J and
S3K). Taken together, these data suggest a functional role for
lncRNA-ATB in inducing EMT. This inducing effect depends on
the competitive binding of miR-200s.
Consistent with the different expression of lncRNA-ATB in the
four HCC cells in Figure S1M, the expression of ZEB1, ZEB2,
N-cadherin, and vimentin were higher and the expression of
E-cadherin and ZO-1 were lower in lncRNA-ATB high expression
cells (Figure S3L), indicating the expression of lncRNA-ATB was
correlated with ZEB1, ZEB2, and EMT features.
To evaluate whether lncRNA-ATB overexpression induced
global EMT-related changes, we performed gene expression mi-
croarray analysis on lncRNA-ATB overexpressed SMMC-7721
cells. GSEA indicated that three published EMT gene signatures
(Alonso et al., 2007; Gotzmann et al., 2006; Huang et al., 2012)
were significantly enriched in lncRNA-ATB overexpressed cells
(Figure 3J), strongly suggesting that lncRNA-ATB overexpres-
sion induces a pervasive and sustained EMT signaling program.
To ascertain the pathological correlation between lncRNA-
ATB and EMT in human HCC samples, we measured E-cadherin
mRNA level in the same set of 86 HCC tissues shown in Figure 2L
and found that lncRNA-ATB transcript level was inversely corre-
lated with E-cadherin mRNA level (Figure 3K), consistent with a
role of lncRNA-ATB in EMT.
To directly test whether lncRNA-ATB could promote inva-
sive behavior by promoting EMT-like morphological changes,
we determined the invasion ability of different SMMC-7721 and
HCCLM6 cell clones using Matrigel-coated transwell experi-
ments. We observed that overexpression of lncRNA-ATB, but
not the mutant or lncRNA-508851, significantly increased the in-
vasion potential of SMMC-7721 cells, and this invasion potential
was completely abolished when miR-200a was overexpressed
(Figure 3L). We also found that depletion of lncRNA-ATB, but
not lncRNA-508851, reduced the invasion potential of HCCLM6
cells, whichwas abrogated by inhibition ofmiR-200a (Figure 3M).
Altogether, these results show that lncRNA-ATB induces EMT
and promotes a more invasive phenotype by competitively bind-
ing miR-200s.
Aberrant Expression of lncRNA-ATB in Human HCC
Tissues
To further define the role of lncRNA-ATB in human HCC, we
measured lncRNA-ATB expression level in the same set of
HCC tissues shown in Figure 2L and in their pair-matched
noncancerous hepatic tissues. The lncRNA-ATB transcript level
was higher in the HCC tissues than in the paired adjacent
noncancerous hepatic tissues (Figure 4A). We next examined
the relationship between lncRNA-ATB expression levels and(J and K) Luciferase activity in stable SMMC-7721 cell clones (J) or HCCLM6 cell
30UTR or nothing. Data are presented as the relative ratio of firefly luciferase activi
***p < 0.001 (Student’s t test).
(L and M) The correlation between lncRNA-ATB transcript level and ZEB1 (L)
(normalized to 18S rRNA) were subjected to Pearson correlation analysis.
See also Figure S2.the clinicopathological characteristics of the 86 HCC samples
(Table S3). Correlation regression analysis showed that high
expression of lncRNA-ATB was significantly correlated with liver
cirrhosis (p = 0.006), microvascular invasion (p = 0.000), macro-
vascular invasion (p = 0.000), and encapsulation (p = 0.007). Por-
tal vein tumor thrombus (PVTT) is the main route for intrahepatic
metastasis of HCC cells in human patients. We examined the
expression of lncRNA-ATB in 40 pairs of PVTT and pair-matched
primary tumor tissues. As shown in Figure 4B, the expression
level of lncRNA-ATB was significantly higher in the PVTT tissues
than in the primary tumor tissues. These data support that a high
level of lncRNA-ATB is strongly associated with the metastasis
of HCC cells.
We further examined whether the lncRNA-ATB expression
level was correlated with the outcome of HCC after hepatec-
tomy. Kaplan-Meier analysis in the 86 patients with HCC re-
vealed that high lncRNA-ATB expression level in HCC tissues
significantly correlated with a reduction in recurrence-free sur-
vival (p < 0.001; Figure 4C) and overall survival (p = 0.004; Fig-
ure 4D), consistent with the important roles of lncRNA-ATB in
the pathogenesis of HCC and the prognosis of HCC.
lncRNA-ATB Promotes the Invasion-Metastasis
Cascade of HCC Cells In Vivo
To evaluate the biological functions of lncRNA-ATB in vivo, we
inoculated different clones of SMMC-7721 and HCCLM6 cells
subcutaneously into nude mice. Neither the overexpression
nor the depletion of lncRNA-ATB had a measurable effect on
the growth of tumors and the proportion of proliferating (Ki67+)
cancer cells (Figures S4A and S4B; data not shown). We then
used subcutaneous tumor tissues to establish orthotopic tu-
mor models. In this model system, lncRNA-ATB overexpres-
sion effectively promoted intrahepatic, mesenteric, pulmonic,
and diaphragmatic metastases in SMMC-7721 cells. However,
mutating the miR-200s binding sites or overexpressing miR-
200a only partially abolished the prometastatic role of lncRNA-
ATB (Figure 5A; Figures S4C andS4D).We next included a stable
SMMC-7721 cell clone with inhibition of miR-200a (Figure S4E)
and found that inhibition of miR-200a promoted metastases
of SMMC-7721 cells, but the prometastatic role is weaker than
that of lncRNA-ATB (Figure 5A; Figure S4C). The depletion of
lncRNA-ATB inhibited intrahepatic, mesenteric, and pulmonic
metastases in HCCLM6 cells, which was also partially abolished
by inhibition of miR-200a (Figure 5B). This implies that miR-200s
is most likely not the only functional downstream effector of the
prometastatic role of lncRNA-ATB.
Because metastasis is a complex multistep process that in-
volves the early step of tumor invasion and the late step of met-
astatic colonization in distant organs, we aimed to explore the
influence of lncRNA-ATB and miR-200s on the different stages
of metastasis. We labeled the different clones with green fluores-
cent protein (GFP) and established orthotopic tumor models,clones (K) transfected with luciferase reporters containing ZEB1 30UTR, ZEB2
ty to renilla luciferase activity. For (A–K), n = 3, mean ± SD. *p < 0.05, **p < 0.01,
or ZEB2 (M) mRNA level was measured in 86 HCC tissues. The DCt values
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Figure 4. Aberrant Expression of lncRNA-ATB in Clinical Samples
(A) lncRNA-ATB expression in human HCC tissues and paired adjacent
noncancerous hepatic tissues. (B) lncRNA-ATB expression in PVTT tissues
and paired primary HCC tissues. For (A) and (B), the expression level of
lncRNA-ATB was analyzed by qRT-PCR. The horizontal lines in the box plots
represent the medians, the boxes represent the interquartile range, and the
whiskers represent the 2.5th and 97.5th percentiles. The significant differences
between samples were analyzed using the Wilcoxon signed-rank test.
(C and D) Kaplan-Meier analyses of the correlations between lncRNA-ATB
expression level and recurrence-free survival (C) or overall survival (D) of 86
patients with HCC. The median expression level was used as the cutoff.
Patients with lncRNA-ATB expression values below the 50th percentile were
classified as having lower lncRNA-ATB levels. Patients with lncRNA-ATB
expression values above the 50th percentile were classified as having higher
lncRNA-ATB levels.
See also Table S3.
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flow cytometry from whole-blood samples. As shown in Fig-
ure 5C and Figure S4F, ectopic expression of lncRNA-ATB
significantly increased the number of CTCs, and the mutation
of the miR-200s binding sites or overexpressing miR-200a
completely abolished the increase. Inhibition of miR-200a also
increased the number of CTCs, which is comparable to that of
overexpression of lncRNA-ATB. Reciprocally, the depletion of
lncRNA-ATB significantly decreased the number of CTCs, whichFigure 3. The Effects of lncRNA-ATB on EMT and Invasion In Vitro
(A) Phase-contrast micrographs of indicated SMMC-7721 cell clones. Scale bar
(B and C) The mRNA (B) or protein (C) levels of EMT markers in indicated SMMC
(D) Immunofluorescence microscopy analysis of the localization and expression
(E) Phase-contrast micrographs of indicated HCCLM6 cell clones. Scale bars re
(F and G) The mRNA (F) or protein (G) levels of EMT markers in indicated HCCLM
(H and I) Phase-contrast micrographs (H) or the protein levels of EMT markers (I
induced EMT. Scale bars represent 100 mm.
(J) GSEA of EMT gene signatures in lncRNA-ATB overexpressed SMMC-7721 c
(K) The correlation between lncRNA-ATB transcript level and E-cadherin mRNA le
were subjected to Pearson correlation analysis.
(L and M) Indicated SMMC-7721 cell clones (L) or HCCLM6 cell clones (M) were a
per field was counted after 48 hr. Data are shown as mean ± SD n = 3. *p < 0.05was abolished by inhibition of miR-200a (Figure 5D). We also
analyzed the levels of human LINE1 DNA, another indicator of
CTCs, by qPCR of genomic DNA from whole-blood samples.
The results were consistent with that of measuring GFP-positive
CTCs (Figures 5E and 5F). These data demonstrated that
lncRNA-ATB promoted intravasation of HCC cells, which was
dependent on the competitive binding of miR-200s.
Consistent with in vitro results, ZEB1, ZEB2, N-cadherin,
and vimentin were upregulated, and E-cadherin and ZO-1 were
reduced in the orthotopic tumor tissues with lncRNA-ATB over-
expression or miR-200a inhibition. In addition, the mutation of
the miR-200s binding sites or overexpression of miR-200a
completely abolished the effects (Figures S4G–S4J). These
data suggest that lncRNA-ATB upregulates ZEB1 and ZEB2, in-
duces EMT, and promotes tumor invasion in vivo, all of which
depend on miR-200s.
To explore the influence of lncRNA-ATB on liver colonization,
we labeled the different clones with firefly luciferase and inocu-
lated cells intrasplenically into nude mice. Overexpression of
lncRNA-ATB resulted in greater livermetastasesburden. Themu-
tation of the miR-200s binding sites or overexpression of miR-
200a, which induced MET in the liver metastases (Figure S4K),
however, did not change this liver metastases-promoting role of
lncRNA-ATB. Inhibition of miR-200a also did not influence liver
metastases (Figures 5G and 5H; Figures S4L and S4M). The
depletion of lncRNA-ATB reduced the liver metastases burden
of HCCLM6 cells, which was also not abolished by inhibition of
miR-200a (Figures 5I and 5J; Figures S4N and S4O). We further
explored the role of lncRNA-ATB in lung colonization by inocu-
lating cells directly into the tail veins of nude mice. We also
observed an increase in the lung metastases burden generated
by lncRNA-ATB-overexpressingSMMC-7721cells. Themutation
of the miR-200s binding sites or overexpression of miR-200a did
not abolish this lung metastases-promoting role of lncRNA-ATB.
InhibitionofmiR-200aalsodidnot influence lungmetastases (Fig-
ures 5K and 5L; Figures S4P and S4Q). Reciprocally, the deple-
tion of lncRNA-ATB significantly reduced the lung metastases
burden of HCCLM6 cells, whichwas also not abolished by inhibi-
tion of miR-200a (Figures 5M and 5N; Figures S4R and S4S).
These results demonstrate that lncRNA-ATB promotes the liver
and lung colonization of HCC cells and that this effect is not
dependent on miR-200s or EMT. This suggests that other genes
or signaling pathways are likely to mediate the procolonization
efficiency of lncRNA-ATB. Consistent with in vitro invasion assay
results, the in vivo results also indicated that HCCLM6 is highly
metastatic compared with SMMC-7721 cells.s = 100 mm.
-7721 cell clones.
of EMT markers in indicated SMMC-7721 cell clones. Scale bars = 50 mm.
present 100 mm.
6 cell clones.
) in control and lncRNA-ATB-knockdown SMMC-7721 cells undergoing TGF-
ells versus control cells. NES, normalized enrichment score.
vel was measured in 86 HCC tissues. The DCt values (normalized to 18S rRNA)
dded to the top of transwells coated with Matrigel. The number of invasive cells
, **p < 0.01 (Student’s t test). See also Figure S3.
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11 mRNA
Wenext sought to explore themechanisms behind the potent ef-
fect of lncRNA-ATB on metastatic colonization. Recently, many
lncRNAs have been reported to interact withmRNA and increase
the stability of mRNA (Faghihi et al., 2008; Yoon et al., 2012). To
identify mRNA species bound by lncRNA-ATB, we performed an
RIP to pull down endogenous mRNAs associated with lncRNA-
ATB (Figure 6A) and sequenced the retrieved RNA. Interleukin-
11 (IL-11) was one of the most enriched transcripts (Figure 6B;
Figure S5A; Table S4), which has been reported to activate
STAT3 signaling and confer a survival advantage to metastatic
cells (Calon et al., 2012). Furthermore, GSEA indicated that
KEGG_JAK_STAT signaling pathway from the Molecular Signa-
tures Database (Liberzon et al., 2011) and published distinct IL-
11/STAT3 upregulated gene signatures (Azare et al., 2007; Dauer
et al., 2005; Putoczki et al., 2013) were significantly enriched in
lncRNA-ATB overexpressed cells, whereas IL-11/STAT3 down-
regulated gene signature was negatively enriched (Figure 6C).
We thus reasoned that lncRNA-ATB may promote metastatic
cell survival through IL-11 mRNA binding, autocrine induction
of IL-11, and activation of IL-11/STAT3 signaling. Promisingly,
we discovered that the liver metastases generated in the intra-
splenically inoculated model displayed higher expression of IL-
11 and more accumulation of p-STAT3 when derived from the
lncRNA-ATB-overexpressing SMMC-7721 cells, and lower
expression of IL-11 and less accumulation of p-STAT3 derived
from lncRNA-ATB-downregulated HCCLM6 cells (Figures S5B
and S5C).
Using BLAST (http://blast.ncbi.nlm.nih.gov/), we identified
six regions of high complementary between lncRNA-ATB and
IL-11 mRNA, but none for b-actin mRNA (Figure 6D). We then
mutated all six binding sites in lncRNA-ATB. To validate thedirect
interaction of lncRNA-ATB with IL-11 mRNA, we performed RIP-
qPCR and the results demonstrated that the lncRNA-ATB RIP
in SMMC-7721 cells is significantly enriched for IL-11 mRNA
compared to the empty vector, IgG, b-actin mRNA, IL-11 binding
sitesmutated lncRNA-ATB (lncRNA-ATB-mut(IL-11)), or lncRNA-
508851, which did not have a complementary region with IL-11
mRNA (Figure 6E). The specific association between lncRNA-
ATB and IL-11 mRNA was further validated by affinity pull-
down of endogenous IL-11 mRNA using in vitro transcribedFigure 5. The Roles of lncRNA-ATB in the Invasion-Metastasis Cascad
(A and B) Incidence of metastases 8 weeks after orthotopic xenografting in nude
(Fisher’s exact test).
(C and D) The number of GFP labeled CTCs was examined by flow cytometry fro
SMMC-7721 cell clones (C) or HCCLM6 cell clones (D). PBMC, peripheral blood
(E and F) Relative levels of human LINE1 DNA were analyzed by qPCR of genomic
n = 10, nonparametric Mann-Whitney U test.
(G) Luciferase signal intensities of mice in each group 6 weeks after intrasplenic in
plots represent the medians, the boxes represent the interquartile range, and the
(H) Number of liver metastases in mice from (G).
(I) Luciferase signal intensities of mice in each group 6 weeks after intrasplenic in
(J) Number of liver metastases in mice from (I).
(K) Luciferase signal intensities of mice in each group 5 weeks after tail vein injec
(L) Number of metastatic nodules in the lungs from the mice in (K) (five sections
(M) Luciferase signal intensities of mice in each group 5 weeks after tail vein inje
(N) Number of metastatic nodules in the lungs from the mice in (M) (five sections
Bars represent mean ± SD. **p < 0.01, ***p < 0.001. See also Figure S4.biotin-labeled lncRNA-ATB (Figure 6F). These results suggest
that lncRNA-ATB interacts with IL-11 mRNA.
To test whether lncRNA-ATB regulates the stability of IL-11
mRNA, we treated different clones of SMMC-7721 and HCCLM6
cells with a-amanitin to block new RNA synthesis and then
measured the loss of IL-11, b-actin, and 18S rRNA over a 24 hr
period. The overexpression of lncRNA-ATB, but not lncRNA-
ATB-mut(IL-11) or lncRNA-508851, elongated the half-life of
IL-11 mRNA, and conversely, the depletion of lncRNA-ATB
shortened the half-life of IL-11 mRNA (Figure 6G). Collectively,
these data demonstrate that lncRNA-ATB specially increases
the stability of IL-11 mRNA, which depends on the binding of
IL-11 mRNA.
lncRNA-ATB Activates IL-11/STAT3 Signaling
To further validate the effects of lncRNA-ATB on IL-11/STAT3
signaling in vitro, we measured IL-11 mRNA levels in different
clones of SMMC-7721 and HCCLM6 cells and found that the
overexpression of lncRNA-ATB, but not lncRNA-ATB-mut(IL-
11) or lncRNA-508851, significantly increased IL-11mRNA levels
in a dose-dependent manner, and ectopic expression of miR-
200a did not change the effects (Figure 6H). Reciprocally, the
depletion of lncRNA-ATB significantly reduced IL-11 mRNA
levels in a dose-dependent manner, whichwas also not changed
by inhibition of miR-200a (Figure 6I). Consistent with the different
expression of lncRNA-ATB in the four HCC cells in Figure S1M,
the expression of IL-11 was higher in lncRNA-ATB high expres-
sion cells (Figure S5D). We also found that overexpression of
lncRNA-ATB upregulated IL-11 mRNA level in QSG-7701 cells
(Figure S5E). To examine whether lncRNA-ATB increases IL-11
secretion and activates IL-11/STAT3 signaling, we measured
IL-11 levels in the cell supernatants and phosphorylation levels
of STAT3 in different clones. The overexpression of lncRNA-
ATB, but not lncRNA-ATB-mut(IL-11) or lncRNA-508851, leads
to increased IL-11 levels in the cell supernatants and phosphor-
ylation levels of STAT3 in a dose-dependent manner (Figures 6J
and 6K). Reciprocally, the depletion of lncRNA-ATB leads
to reduced IL-11 levels in the cell supernatants and phos-
phorylation levels of STAT3 in a dose-dependent manner
(Figures 6L and 6M). Neither overexpression nor inhibition of
miR-200a changed the effects (Figures 6J–6M). Overexpression
of lncRNA-ATB also upregulated IL-11 levels in the celle of HCC Cells
mice using indicated SMMC-7721 cell clones (A) or HCCLM6 cell clones (B)
m whole-blood samples 5 weeks after orthotopic xenografting using indicated
mononuclear cells.
DNA from the blood in (C) and (D), normalized to mouse LINE1 DNA. For (C–F),
jection with 23 106 indicated SMMC-7721 cells. The horizontal lines in the box
whiskers represent the minimum and maximum values.
jection with 2 3 106 indicated HCCLM6 cells. Data are shown as in (G).
tion with 1 3 106 indicated SMMC-7721 cells. Data are shown as in (G).
evaluated per lung).
ction with 1 3 106 indicated HCCLM6 cells. Data are shown as in (G).
evaluated per lung). For (G–N), n = 6, nonparametric Mann-Whitney U test.
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cells (Figures S5F and S5G). STAT3 downstream target protein
BCL2 was also upregulated by overexpression of lncRNA-
ATB, but not lncRNA-ATB-mut(IL-11) or lncRNA-508851, and
was downregulated by depletion of lncRNA-ATB (Figures
S5H–S5J). These results indicate that lncRNA-ATB upregulated
the expression of IL-11, increased IL-11 secretion, and activated
STAT3 signaling in an autocrine manner. The effects of
lncRNA-ATB on IL-11/STAT3 signaling are not dependent on
miR-200s.
To confirm the regulation of IL-11 by lncRNA-ATB in human
HCC tissues, we measured IL-11 mRNA level in the same set
of 40 pairs of PVTT and pair-matched primary HCC tissues
shown in Figure 4B and found that IL-11 mRNA level was signif-
icantly higher in the PVTT tissues than in the primary HCC tissues
(Figure 6N). Importantly, the IL-11 mRNA level is correlated with
the lncRNA-ATB transcript level in the PVTT tissues (Figure 6O).
These clinical data demonstrated that IL-11 may be associated
with the metastasis of HCC cells and were consistent with the
role of lncRNA-ATB in the regulation of IL-11.
lncRNA-ATB Requires IL-11/STAT3 Signaling to
Promote Colonization
To test the contribution of IL-11 to the procolonization role of
lncRNA-ATB, we knocked down IL-11 in lncRNA-ATB-overex-
pressing SMMC-7721 clone 1. This knockdown has no signifi-
cant effect on lncRNA-ATB expression (Figure 7A). We first
measured the effects of IL-11 on EMT, and found that knock-
down of IL-11 did not induce or invert EMT (Figure S6A). Next,
we found that the mutation of IL-11 binding sites or knockdown
of IL-11 also did not change the proinvasive efficiency of
lncRNA-ATB (Figure S6B).
The cells were labeled with firefly luciferase and inoculated in-
trasplenically into nude mice. During the first few days following
inoculation, most of the cells that reached the liver were progres-
sively lost, and by 7 days, tumor cells were barely detectable.
The overexpression of lncRNA-ATB, but not lncRNA-ATB-mu-
t(IL-11), significantly increased the number of cells detected at
the early time points and inducedmoremetastatic foci in the liverFigure 6. lncRNA-ATB Interacts with IL-11 mRNA and Activates IL-11/
(A) A schematic outline of the MS2-RIP strategy used to identify endogenous mR
(B) lncRNA-ATB-MS2 RIP-seq identification of IL-11 enrichment in anti-GFP and
(C) GSEA of KEGG_JAK_STAT signaling pathway and published IL-11/STAT3 regu
control cells. NES, normalized enrichment score.
(D) Regions of putative interaction between lncRNA-ATB (query) and IL-11 mRN
(E) RIP-derived RNA was measured by qRT-PCR. The levels of qRT-PCR produc
(F) SMMC-7721 cell lysates were incubated with biotin-labeled lncRNA-ATB; afte
as in (E).
(G) The stability of IL-11 and b-actin mRNA over time was measured by qRT-PCR
indicated SMMC-7721 cell clones or HCCLM6 cell clones and normalized to 18S
(H and I) Relative IL-11 mRNA levels in indicated SMMC-7721 cell clones (H) or
(J and K) Concentration of IL-11 in the culture medium measured by ELISA (J) or p
clones.
(L and M) Concentration of IL-11 in the culture medium measured by ELISA (L) o
clones. For (E–M), n = 3, mean ± SD, Student’s t test, *p < 0.05, **p < 0.01, ***p
(N) IL-11mRNA levels in primary HCC and PVTT tissues from the same set of patie
plots represent the medians, the boxes represent the interquartile range, and the
(O) The correlation between lncRNA-ATB transcript level and IL-11 mRNA leve
(normalized to 18S rRNA) were subjected to Pearson correlation analysis.
See also Figure S5 and Table S4.at the late time point. The knockdown of IL-11 in lncRNA-ATB-
overexpressing cells reduced the amounts to near those of the
control cells (Figures 7B–7E). We further explored the role of
lncRNA-ATB and IL-11 in lung colonization by injecting cells
directly into the tail veins of nude mice. lncRNA-ATB overex-
pressing cells, but not that of lncRNA-ATB-mut(IL-11), displayed
increased lung colonization rates at the early time points and
formed more metastatic tumors in the lung at the late time point,
whereas knockdown of IL-11 mostly abolished this increase
(Figures 7F–7I). These data demonstrated that lncRNA-ATB
enhances the colonization potential of HCC cells and this effect
depends on IL-11.
DISCUSSION
In this study, we report that lncRNA-ATB, which could be acti-
vated by TGF-b, promotes HCC cell invasion by competitively
binding the miR-200 family, upregulating ZEB1 and ZEB2, and
then inducing EMT. On the other hand, lncRNA-ATB promotes
HCC cell colonization at the site of metastasis by binding IL-11
mRNA, increasing IL-11 mRNA stability, causing autocrine in-
duction of IL-11, and then activating STAT3 signaling. Therefore,
lncRNA-ATB plays a prometastatic role in HCC (Figure 8). We
also found that the expression of lncRNA-ATB was increased
in HCC andwas further increased in PVTT. Furthermore, a higher
level of lncRNA-ATB was associated with tumor invasion in
patients with HCC and was inversely correlated with prognosis.
All these data support our conclusion that lncRNA-ATB has
pleiotropic effects on HCC cell invasion, colonization, and
metastasis. Therefore, lncRNA-ATB was determined to have
oncogenic activity.
Our results indicated that a higher level of lncRNA-ATB was
associated with liver cirrhosis in patients with HCC, which is
consistent with the observation that TGF-b is also associated
with liver cirrhosis (Yang et al., 2013). A recent report indicated
that the level of TGF-b signaling activity was higher in PVTT tis-
sues than the primary HCC tissues (Yang et al., 2012), which
further supports the regulation of lncRNA-ATB by TGF-b in vivo.
The biphasic activities of the TGF-b signaling pathway duringSTAT3 Signaling in HCC Cells
NA:lncRNA-ATB binding.
nonspecific IgG groups.
lated gene signatures in lncRNA-ATB overexpressed SMMC-7721 cells versus
A (subject).
ts were expressed as a percentage of input RNA.
r pull-down, mRNA was extracted and assessed by qRT-PCR. Data are shown
relative to time 0 after blocking new RNA synthesis with a-amanitin (50 mM) in
rRNA (a product of RNA polymerase I that is unchanged by a-amanitin).
HCCLM6 cell clones (I).
-STAT3 levels determined by western blot (K) from indicated SMMC-7721 cell
r p-STAT3 levels determined by western blot (M) from indicated HCCLM6 cell
< 0.001.
nts as in Figure 4B were measured by qRT-PCR. The horizontal lines in the box
whiskers represent the 2.5th and 97.5th percentiles. Wilcoxon signed-rank test.
l was measured in the same set of PVTT tissues as in (N). The DCt values
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Figure 7. The Pro-Colonization Role of lncRNA-ATB Requires IL-11/STAT3 Signaling
(A) The expression levels of IL-11 and lncRNA-ATB were determined by qRT-PCR. n = 3, Student’s t test.
(B) Luciferase signal intensities of the mice in each group over time after intrasplenic injection with 2 3 106 indicated SMMC-7721 cell clones.
(C) Representative images of mice from (B) over time.
(D) The number of liver metastases in the mice from (B) 35 days after intrasplenic injection.
(E) Representative livers from (D).
(F) Luciferase signal intensities of mice over time after tail vein injection with 1 3 106 indicated SMMC-7721 cell clones.
(G) Representative images of the mice from (F) over time.
(H) The number of metastatic nodules in the lungs from (F) 28 days after tail vein injection (five sections evaluated per lung).
(I) Hematoxylin and eosin-stained images of lung tissues isolated from themice in (H). Scale bars represent 500 mm. For (B–I), n = 6, nonparametric Mann-Whitney
U test; arrows indicate the metastasis nodules. Data are shown as mean ± SD, **p < 0.01. See also Figure S6.
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Figure 8. A Schematic Model of lncRNA-ATB Functions during the
Invasion-Metastasis Cascade
lncRNA-ATB, which could be activated by TGF-b, promotes HCC cell invasion
by competitively binding the miR-200 family, upregulating ZEB1 and ZEB2,
and then inducing EMT. On the other hand, lncRNA-ATB promotes HCC cell
colonization at the site of metastases by binding IL-11 mRNA, increasing IL-11
mRNA stability, causing autocrine induction of IL-11, and then activating
STAT3 signaling.
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lncRNA-ATB Promotes Invasion-Metastasis Cascadetumorigenesis hinder its utilization in clinical treatment. There-
fore, it would be beneficial to target the tumor-progressing arm
of TGF-b action while avoiding the tumor-suppressing arm.
Thus, the specific downstream effectors of the different TGF-b
signaling pathways need to be explored further. In this study,
we identified that lncRNA-ATB mediates the role of TGF-b in
inducing EMT and promoting metastasis. Promisingly, lncRNA-
ATB was activated by TGF-b and induced EMT not only in
HCC cells, but also in colorectal cancer and breast cancer cells,
indicating that lncRNA-ATB is a more general TGF-b mediator.
Our results indicated that a short-term TGF-b treatment was suf-
ficient to activate lncRNA-ATB, which implied that lncRNA-ATB
may be a direct target of TGF-b/Smad pathway, but how TGF-
b activates lncRNA-ATB requires further investigation.
In this study, we found that lncRNA-ATB shares miR-200s
response elements with ZEB1 and ZEB2, the master inducers
of EMT. In our in vitro system, an orthotopic xenograft model
of nude mice and clinical HCC tissues, we observed that ectopic
expression of lncRNA-ATB was sufficient to increase ZEB1 and
ZEB2 and induce EMT. The mRNA expression profile after over-
expressing of lncRNA-ATB fortified its role in inducing EMT.
Notably, this role depends on the competitive binding of miR-
200s, indicating that lncRNA-ATB functions as a ceRNA.
Because there is a double negative feedback loop between
miR-200s and ZEB1/ZEB2 (Burk et al., 2008), the upregulation
of ZEB1 and ZEB2 by lncRNA-ATB could further augment the ef-
fects. It is widely recognized that EMT facilitates tumor invasion
and dissemination (Massague´, 2008). Consistently, in our in vitro
system, an orthotopic xenograft model of nude mice and clinical
HCC tissues, we all found that by inducing EMT, lncRNA-ATB
promotes HCC cell invasion.
In the orthotopic xenograft model in nude mice, we found
that lncRNA-ATB promoted HCC cell metastases, which were
not completely dependent on miR-200s or EMT. This implies
that metastasis is not only determined by the invasion potentialand that the miR-200-ZEB-EMT axis is not the only downstream
effector of lncRNA-ATB. Metastasis is a complex multistep
process that involves early invasion and late colonization of can-
cer cells (Tao et al., 2013). Clinical observations and animal
model studies have indicated that, despite the significant and
continuous tumor cell intravasation into the circulation, only a
small minority of these cells colonize a distant organ (Gupta
and Massague´, 2006). Therefore, colonization is a rather
inefficient process and also has a critical influence on ultimate
metastasis. In our tail vein injection and intrasplenic inoculation
xenograft models, we found that the miR-200-EMT axis had no
significant effect on colonization. Therefore, lncRNA-ATB exerts
its procolonization effect through other pathways.
We combined RIP-seq and transcriptome analysis to identify
that lncRNA-ATB bound IL-11 mRNA, increased IL-11 mRNA
stability, and caused autocrine induction of IL-11, and activated
IL-11/STAT3 signaling, which were further verified in our in vitro
system, the xenograft metastasis model, and clinical HCC tis-
sues. In our xenograft model using nude mice, IL-11 secreted
by HCC cells contributes to the procolonization role of lncRNA-
ATB, because the depletion of IL-11 in HCC cells abolished the
procolonization effect of lncRNA-ATB. The depletion of IL-11
did not induce or invert EMT, indicating that the role of lncRNA-
ATB or IL-11 in colonization is not dependent on EMT or MET.
Taken together, our research demonstrated that lncRNA-ATB
acts as a key regulator of TGF-b signaling pathways and
revealed roles of TGF-b in regulating long noncoding RNAs.
The findings of this study have significant implications regarding
our understanding of HCC metastasis pathogenesis. As direct
targets of lncRNA-ATB, miR-200-ZEB and IL-11 mediated the
role of lncRNA-ATB in local invasion and distant colonization,
respectively. The pleiotropic effects of lncRNA-ATB on the early
and late steps of the invasion-metastasis cascade suggest
that lncRNA-ATB could be an effective target for antimetastasis
therapies.EXPERIMENTAL PROCEDURES
Patients
Frozen HCC tissues, normal liver tissues, and PVTT tissues were randomly ob-
tained with informed consent from patients who underwent radical resections
in the Eastern Hepatobiliary Surgery Hospital (Second Military Medical Univer-
sity, Shanghai, China). Ethical consent was granted from the Committees
for Ethical Review of Research involving Human Subjects of Second Military
Medical University.Animal Studies
The animal studies were approved by the Institutional Animal Care and Use
Committee of the Second Military Medical University. Male athymic BALB/c
nude mice (4–5 weeks old) were used for animal studies. Subcutaneous tumor
growth assays were performed as previously described (Yuan et al., 2011).
Orthotopic xenograft model and metastasis model are described in the Sup-
plemental Experimental Procedures.Statistical Analysis
All statistical analyses were performed using the GraphPad Prism Software
(GraphPad Software). For comparisons, Student’s t test (two-tailed), Wil-
coxon signed-rank test, Pearson chi-square test, Pearson correlation anal-
ysis, Log-rank test, Fisher’s exact test, and nonparametric Mann-Whitney
U test were performed as indicated. A p value < 0.05 was considered
significant.Cancer Cell 25, 666–681, May 12, 2014 ª2014 Elsevier Inc. 679
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The Gene Expression Omnibus accession numbers for the lncRNA microarray
data for TGF-b-treated cells, gene expression data for lncRNA-ATB overex-
pressed SMMC-7721 cells, and RIP-seq data of lncRNA-ATB are GSE54797,
GSE54798, and GSE54799, respectively.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and four tables and can be found with this article online at http://
dx.doi.org/10.1016/j.ccr.2014.03.010.
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